Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000031202 | SCV000244377 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2015-08-10 | reviewed by expert panel | curation | IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.00000389 |
Labcorp Genetics |
RCV001081025 | SCV000076744 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000758838 | SCV000209982 | likely benign | not provided | 2018-03-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28283652, 17308087, 20378548, 14534301, 20516115, 26727311, 21447777, 15172985, 24489791, 30209399) |
Ambry Genetics | RCV000221221 | SCV000278635 | benign | Hereditary cancer-predisposing syndrome | 2015-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000758838 | SCV000887707 | likely benign | not provided | 2018-03-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000221221 | SCV001358819 | likely benign | Hereditary cancer-predisposing syndrome | 2019-04-02 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000031202 | SCV004817606 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Sharing Clinical Reports Project |
RCV000031202 | SCV000053802 | benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2012-05-01 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000031202 | SCV000145255 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 1 | 2002-05-29 | no assertion criteria provided | clinical testing | |
Brotman Baty Institute, |
RCV000031202 | SCV001243345 | not provided | Breast-ovarian cancer, familial, susceptibility to, 1 | no assertion provided | in vitro |